Skip to main content
2026 CRT Conference Main banner

CRT 2026

Power Break Symposium

Session:: Power Break Symposium | The Future of HTN Care Is Now: The Symplicity™ Blood Pressure Procedure [Non-CME] – Sponsored by Medtronic

Patient Selection and Safety

Sunday, March 8, 2026
12:47 PM - 12:52 PM EST
Location: International Ballroom West

    Speaker(s)

  • Rasha Al-Lamee, MA, MD, PhD

    Interventional Cardiology Consultant
    Imperial College London
    London, England, United Kingdom

    Disclosure(s): Abbott Vascular,: Consulting Fees (e.g., advisory boards) (Ongoing); AstraZeneca Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Ongoing); CathWorks: Consulting Fees (e.g., advisory boards) (Ongoing); Jannsen: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Philips Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Shockwave Medical: Consulting Fees (e.g., advisory boards) (Ongoing)

  • Raymond R. Townsend, MD

    Professor
    University of Pennsylvania, Pennsylvania, United States

    Disclosure(s): AstraZeneca: Consulting Fees (e.g., advisory boards) (Ongoing); BSC, Amgen, BCRI, PERC, NAMSA, BMS, Janssen, Regeneron: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic, Novartis, OrbusNeich, Penumbra, PhaseBio, Philips, Pi-Cardia, PLx Pharma, Protembis, RenalPro, RM Global, Shockwave, Vivasure, Zoll: Consulting Fees (e.g., advisory boards) (Ongoing)

Disclosure(s):
Rasha Al-Lamee, MA, MD, PhD: Abbott Vascular,: Consulting Fees (e.g., advisory boards) (Ongoing); AstraZeneca Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Ongoing); CathWorks: Consulting Fees (e.g., advisory boards) (Ongoing); Jannsen: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Philips Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Shockwave Medical: Consulting Fees (e.g., advisory boards) (Ongoing)
Raymond R. Townsend, MD: AstraZeneca: Consulting Fees (e.g., advisory boards) (Ongoing); BSC, Amgen, BCRI, PERC, NAMSA, BMS, Janssen, Regeneron: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic, Novartis, OrbusNeich, Penumbra, PhaseBio, Philips, Pi-Cardia, PLx Pharma, Protembis, RenalPro, RM Global, Shockwave, Vivasure, Zoll: Consulting Fees (e.g., advisory boards) (Ongoing)